Global Plasma Fractionation Market Growth 2024-2030
Plasma Fractionation market rises from US$27.49 billion in 2023 to US$46.76 billion by 2030, with a 7.9% CAGR, due to increasing demand in the downstream market.
Blood plasma, the liquid portion of blood, is a life-giving resource. Within its straw-colored depths lies a treasure trove of proteins, numbering in the thousands, each playing a vital role in maintaining health. The global blood plasma fractionation market capitalizes on this potential, transforming donated plasma into a powerful tool for treating a multitude of diseases. Plasma is akin to the body's internal river system, transporting nutrients, hormones, and waste products throughout the body. But its most valuable cargo is a collection of proteins, some well-known like albumin and globulins, and others waiting to be fully explored. These proteins are the workhorses of our immune system, the architects of blood clots, and the transport vehicles for delivering oxygen and nutrients to our cells. They act as enzymes speeding up vital biochemical reactions, and even help regulate fluid balance in our tissues.
According to our publisher’s latest study, the global Plasma Fractionation market size was valued at US$ 27490 million in 2023. With growing demand in downstream market, the Plasma Fractionation is forecast to a readjusted size of US$ 46760 million by 2030 with a CAGR of 7.9% during review period.
The research report highlights the growth potential of the global Plasma Fractionation market. Plasma Fractionation are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Plasma Fractionation. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Plasma Fractionation market.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
Key Features:
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Manmayi Raval
Research Consultant
The report on Plasma Fractionation market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Plasma Fractionation market. It may include historical data, market segmentation by Type (e.g., Albumin, Immune Globulin), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Plasma Fractionation market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Market Drivers:
• Disease Burden: Rising prevalence of chronic illnesses like immunodeficiencies and hemophilia fuels demand for plasma-derived therapies.
• Aging Population: As populations age, the need for these treatments to address weakened immune systems is expected to climb.
Market Trends:
• Technological Advancements: Improved fractionation techniques are leading to purer, more effective plasma-derived products.
• Emerging Market Focus: Developing economies with growing healthcare infrastructure are presenting new opportunities for market expansion.
Market Challenges:
• Plasma Shortage: The global demand for plasma often outpaces the readily available supply, especially in developing regions.
• High Costs: Developing, manufacturing, and storing plasma-derived therapies can be expensive, limiting access in some areas.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Plasma Fractionation market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Plasma Fractionation industry. This include advancements in Plasma Fractionation technology, Plasma Fractionation new entrants, Plasma Fractionation new investment, and other innovations that are shaping the future of Plasma Fractionation.
• Precision Fractionation: New techniques like chromatography and membrane filtration are improving the purity and yield of isolated proteins, leading to more potent and targeted therapies.
• Viral Inactivation Methods: Enhanced viral inactivation methods like solvent/detergent treatment and nanofiltration ensure the safety and efficacy of plasma-derived products.
• Automation on the Rise: Automation in plasma collection and processing is streamlining operations, increasing efficiency, and potentially reducing costs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Plasma Fractionation market. It includes factors influencing customer ' purchasing decisions, preferences for Plasma Fractionation product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Plasma Fractionation market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Plasma Fractionation market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Plasma Fractionation market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Plasma Fractionation industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
• Rising Demand: Growing prevalence of chronic diseases and an aging population will increase the need for plasma-derived therapies.
• Technological Advancements: Innovations in fractionation techniques will improve product yield, purity, and potentially unlock new applications.
• Emerging Market Boom: Developing economies with expanding healthcare infrastructure present significant growth potential.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Plasma Fractionation market.
• Combatting Chronic Diseases: Rising prevalence of conditions like immunodeficiencies creates demand for plasma-derived therapies as crucial weapons in the fight.
• Aging Advantage: An aging population translates to a growing need for these therapies to treat age-related conditions affecting the immune system.
• Tech Triumphs: Advancements in fractionation techniques promise improved yields and purer plasma products, enhancing their effectiveness.
Market Segmentation:
Plasma Fractionation market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Albumin
Immune Globulin
Coagulation Factor
Others
Segmentation by application
Immunology
Hematology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma Fractionation Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Plasma Fractionation by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Plasma Fractionation by Country/Region, 2019, 2023 & 2030
2.2 Plasma Fractionation Segment by Type
2.2.1 Albumin
2.2.2 Immune Globulin
2.2.3 Coagulation Factor
2.2.4 Others
2.3 Plasma Fractionation Sales by Type
2.3.1 Global Plasma Fractionation Sales Market Share by Type (2019-2024)
2.3.2 Global Plasma Fractionation Revenue and Market Share by Type (2019-2024)
2.3.3 Global Plasma Fractionation Sale Price by Type (2019-2024)
2.4 Plasma Fractionation Segment by Application
2.4.1 Immunology
2.4.2 Hematology
2.4.3 Others
2.5 Plasma Fractionation Sales by Application
2.5.1 Global Plasma Fractionation Sale Market Share by Application (2019-2024)
2.5.2 Global Plasma Fractionation Revenue and Market Share by Application (2019-2024)
2.5.3 Global Plasma Fractionation Sale Price by Application (2019-2024)
3 Global Plasma Fractionation by Company
3.1 Global Plasma Fractionation Breakdown Data by Company
3.1.1 Global Plasma Fractionation Annual Sales by Company (2019-2024)
3.1.2 Global Plasma Fractionation Sales Market Share by Company (2019-2024)
3.2 Global Plasma Fractionation Annual Revenue by Company (2019-2024)
3.2.1 Global Plasma Fractionation Revenue by Company (2019-2024)
3.2.2 Global Plasma Fractionation Revenue Market Share by Company (2019-2024)
3.3 Global Plasma Fractionation Sale Price by Company
3.4 Key Manufacturers Plasma Fractionation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma Fractionation Product Location Distribution
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More